Abstract
Of 89 samples of cancer cells from ovarian cancer patients primary cultures representative of the cancer cell population could be established in 17. The clinical response to polychemotherapy was studied in relation to the inhibition of thymidine uptake by the cultured cells. Cultures of each patient's tumour were exposed to concentrations of the drugs the patients had been given for long enough to reproduce the area under the curve (AUC) of the plasma levels resulting from in vivo dosage. Full agreement was observed between the degree of thymidine uptake inhibition induced by at least one of the drugs administered to the cultured cells and the degree of clinical response. This approach may prove useful in pharmacological studies as a means of obtaining ovarian cancer cell populations representative of human tumours, even though the number of tumours that can be successfully evaluated in vitro is still too small to serve as a sound basis for prediction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Morasca, L., Erba, E., Vaghi, M. et al. Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. Br J Cancer 48, 61–68 (1983). https://doi.org/10.1038/bjc.1983.157
Issue Date:
DOI: https://doi.org/10.1038/bjc.1983.157
This article is cited by
-
Stability of solutions of antineoplastic agents during preparation and storage for in vitor assays
Cancer Chemotherapy and Pharmacology (1985)